Journal of Substance Abuse Treatment
Volume 36, Issue 3 , Pages 235-243 , April 2009

The relevance and treatment of cue-induced cravings in tobacco dependence

  • Stuart G. Ferguson, Ph.D.
    • ,
  • Saul Shiffman, Ph.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Pinney Associates, 201 North Craig Street, Suite 320, Pittsburgh, PA 15213, USA. Tel.: +1 412 687 5677; fax: +1 412 687 4855.

Received 17 December 2007 ,Revised 22 May 2008 ,Accepted 22 June 2008.

References 

  1. Abrams DB, Monti PM, Carey KB, Pinto RP, Jacobus SI. Reactivity to smoking cues and relapse: Two studies of discriminant validity. Behaviour Research and Therapy. 1988;26:225–233
  2. Bandura A. Social learning theory. Eaglewood Cliffs, NJ: Prentice-Hall; 1976;
  3. Baumann SB, Sayette MA. Smoking cues in a virtual world provoke craving in cigarette smokers. Psychology of Addictive Behaviors. 2006;20:484–489
  4. Benowitz NL, Porchet H, Sheiner L, Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clinical Pharmacology & Therapeutics. 1988;44:23–28
  5. Bliss RE, Garvey AJ, Heinold JW, Hitchcock JL. The influence of situation and coping on relapse crisis outcomes after smoking cessation. Journal of Consulting and Clinical Psychology. 1989;57:443–449
  6. Bordnick PS, Traylor A, Copp HL, Graap KM, Carter B, Ferrer M, et al. Assessing reactivity to virtual reality alcohol based cues. Addictive Behaviors. 2008;33:743–756
  7. Brandon TH, Piasecki TM, Quinn EP, Baker TB. Cue exposure treatment in nicotine dependence. In:  Drummond DC,  Tiffany ST,  Glautier S,  Remington B editor. Addictive behaviour: Cue exposure theory and practice. New York, NY: John Wiley & Sons; 1995;p. 211–227
  8. Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, et al. Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: A preliminary study. Psychiatry Research. 2004;130:269–281
  9. Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG, et al. Brain metabolic changes during cigarette craving. Archives of General Psychiatry. 2002;59:1162–1172
  10. Carter BL, Tiffany ST. Meta-analysis of cue-reactivity in addiction research. Addiction. 1999;94:327–340
  11. Carter BL, Tiffany ST. The cue-availability paradigm: The effects of cigarette availability on cue reactivity in smokers. Experimental and Clinical Psychopharmacology. 2001;9:183–190
  12. Choi JH, Dresler CM, Norton MR, Strahs KR. Pharmacokinetics of a nicotine polacrilex lozenge. Nicotine & Tobacco Research. 2003;5:635–644
  13. Conklin CA, Tiffany ST. Applying extinction research and theory to cue-exposure addiction treatments. Addiction. 2002;97:155–167
  14. Curry S, Marlatt GA. Strategies for coping with temptations to smoke. In:  Shiffman S,  Wills TA editor. Coping and substance abuse. New York: Academic Press; 1985;p. 243–265
  15. Dale LC, Hurt RD, Offord KP, Lawson GM, Croghan IT, Schroeder DR. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation. Journal of the American Medical Association. 1995;274:1353–1358
  16. David S, Lancaster T, Stead LF, Evins AE. Opioid antagonists for smoking cessation. Cochrane Database of Systematic Reviews. 2006;CD003086
  17. Dols M, van den HM, Kindt M, Willems B. The urge to smoke depends on the expectation of smoking. Addiction. 2002;97:87–93
  18. Durcan MJ, De'Ath J, Targett D, Marsh H, Chan R, Ong TJ. Efficacy of the nicotine lozenge in relieving cue provoked cravings. In: Presented at the Annual European meeting of the Society for Research on Nicotine & Tobacco, Padua, Italy. 2003;
  19. Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, et al. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clinical Therapeutics. 2002;24:540–551
  20. Fant RV, Owen LL, Henningfield JE. Nicotine replacement therapy. Primary Care. 1999;26:633–652
  21. Ferguson SG, Shiffman S, Gwaltney CJ. Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial. Journal of Consulting and Clinical Psychology. 2006;74:1153–1161
  22. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry S, et al. Treating tobacco use and dependence 2008 Update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008;
  23. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association. 2006;296:47–55
  24. Havermans RC, Debaere S, Smulders FT, Wiers RW, Jansen AT. Effect of cue exposure, urge to smoke, and nicotine deprivation on cognitive performance in smokers. Psychology of Addictive Behaviors. 2003;17:336–339
  25. Havermans RC, Jansen AT. Increasing the efficacy of cue exposure treatment in preventing relapse of addictive behavior. Addictive Behaviors. 2003;28:989–994
  26. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML. Pharmacotherapy for nicotine dependence. CA: A Cancer Journal for Clinicians. 2005;55:281–299
  27. Hughes JR. Tobacco withdrawal in self-quitters. Journal of Consulting and Clinical Psychology. 1992;60:689–697
  28. Hurt RD, Offord KP, Croghan IT, Gomez-Dahl LC, Wolter LC. Temporal effects of nicotine nasal spray and gum on nicotine withdrawal symptoms. Psychopharmacology. 1998;140:98–104
  29. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal of Medicine. 1997;337:1195–1202
  30. Hussain S, Zawertailo L, Zack M, Busto U, Selby P. The impact of bupropion on cue-reactivity and the subjective effects of smoking in ad lib smokers. In: Presented at the Annual meeting of the Society for Research on Nicotine & Tobacco, Austin, TX USA. 2007;
  31. Hutchison KE, Monti PM, Rohsenow DJ, Swift RM, Colby SM, Gnys M, et al. Effects of naltrexone with nicotine replacement on smoking cue reactivity: Preliminary results. Psychopharmacology (Berlin). 1999;142:139–143
  32. Hutchison KE, Rutter MC, Niaura R, Swift RM, Pickworth WB, Sobik L. Olanzapine attenuates cue-elicited craving for tobacco. Psychopharmacology (Berlin). 2004;175:407–413
  33. Jarvik ME, Schneider NG. Nicotine. In:  Lowinson JH,  Ruiz P,  Millman R,  Langrod JG editor. Substance abuse: A comprehensive textbook. Baltimore, MD: Williams & Wilkins; 1992;p. 334–356
  34. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association. 2006;296:56–63
  35. Killen JD, Fortmann SP. Craving is associated with smoking relapse: Findings from three prospective studies. Experimental and Clinical Psychopharmacology. 1997;5:137–142
  36. Larowe SD, Saladin ME, Carpenter MJ, Upadhyaya HP. Reactivity to nicotine cues over repeated cue reactivity sessions. Addict Behav. 2007;32:2888–2899
  37. Marlatt GA, Gordon JR. Relapse prevention. New York, NY: Guildford; 1985;
  38. McGeary JE, Monti PM, Rohsenow DJ, Tidey J, Swift R, Miranda R. Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcoholism, Clinical and Experimental Research. 2006;30:1288–1296
  39. Miranda R, Rohsenow DJ, Monti PM, Tidey J, Ray L. Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addictive Behaviors. 2008;33:347–353
  40. Morissette SB, Palfai TP, Gulliver SB, Spiegel DA, Barlow DH. Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers. Psychology of Addictive Behaviors. 2005;19:192–198
  41. Niaura R, Abrams D, Demuth B, Pinto R, Monti P. Responses to smoking-related stimuli and early relapse to smoking. Addictive Behaviors. 1989;14:419–428
  42. Niaura R, Abrams DB, Monti PM, Pedraza M. Reactivity to high risk situations and smoking cessation outcome. Journal of Substance Abuse. 1989;1:393–405
  43. Niaura R, Abrams DB, Pedraza M, Monti PM, Rohsenow DJ. Smokers' reactions to interpersonal interaction and presentation of smoking cues. Addictive Behaviors. 1992;17:557–566
  44. Niaura R, Abrams DB, Shadel WG, Rohsenow DJ, Monti PM, Sirota AD. Cue exposure treatment for smoking relapse prevention: A controlled clinical trial. Addiction. 1999;94:685–695
  45. Niaura R, Hitsman B, Shadel W, DiBernedetti DB, Price LH. Effects of Varenicline on cue-provoked cigarette craving and acute nicotine withdrawal. In: Presented at the Annual meeting of the Society for Research on Nicotine & Tobacco, Austin, TX USA. 2007;
  46. Niaura R, Sayette M, Shiffman S, Glover ED, Nides M, Shelanski M, et al. Comparative efficacy of rapid-release nicotine gum versus nicotine polacrilex gum in relieving smoking cue-provoked craving. Addiction. 2005;100:1720–1730
  47. Niaura R, Shadel WG, Abrams DB, Monti PM, Rohsenow DJ, Sirota A. Individual differences in cue reactivity among smokers trying to quit: Effects of gender and cue type. Addictive Behaviors. 1998;23:209–224
  48. Niaura RS, Rohsenow DJ, Binkoff JA, Monti PM, Pedraza M, Abrams DB. Relevance of cue reactivity to understanding alcohol and smoking relapse. Journal of Abnormal Psychology. 1988;97:133–152
  49. O'Connell KA, Martine EJ. Highly tempting situations associated with abstinence, temporary lapse, and relapse among participants in smoking cessation programs. Journal of Consulting and Clinical Psychology. 1987;55:367–371
  50. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry. 1992;49:881–887
  51. Piasecki TM, Niaura R, Shadel WG, Abrams D, Goldstein M, Fiore MC, et al. Smoking withdrawal dynamics in unaided quitters. Journal of Abnormal Psychology. 2000;109:74–86
  52. Reid MS, Palamar J, Raghavan S, Flammino F. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers. Psychopharmacology (Berlin). 2007;192:147–158
  53. Rohsenow DJ, Monti PM. Does urge to drink predict relapse after treatment?. Alochol Research & Health. 1999;23:225–232
  54. Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, et al. High-dose transdermal nicotine and naltrexone: Effects on nicotine withdrawal, urges, smoking, and effects of smoking. Experimental and Clinical Psychopharmacology. 2007;15:81–92
  55. Sayette MA, Martin CS, Wertz JM, Shiffman S, Perrott MA. A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. Addiction. 2001;96:1419–1432
  56. Sayette MA, Parrott DJ. Effects of olfactory stimuli on urge reduction in smokers. Experimental and Clinical Psychopharmacology. 1999;7:151–159
  57. Sayette MA, Shiffman S, Tiffany ST, Niaura RS, Martin CS, Shadel WG. The measurement of drug craving. Addiction. 2000;95(Suppl 2):S189–S210
  58. Sayette MA, Wertz JM, Martin CS, Cohn JF, Perrott MA, Hobel J. Effects of smoking opportunity on cue-elicited urge: A facial coding analysis. Experimental and Clinical Psychopharmacology. 2003;11:218–227
  59. Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO. Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems. Clinical Pharmacokinetics. 1996;31:65–80
  60. Shiffman S. Relapse following smoking cessation: A situational analysis. Journal of Consulting and Clinical Psychology. 1982;50:71–86
  61. Shiffman S. Coping with temptations to smoke. Journal of Consulting and Clinical Psychology. 1984;52:261–267
  62. Shiffman S. Conceptual issues in the study of relapse. In:  Gossop M editors. Relapse and Addictive Behavior. Kent, England: Croom Helm Ltd; 1989;p. 149–179
  63. Shiffman S. . Smoking cessation treatment: Any progress?. Journal of Consulting and Clinical Psychology. 1993;61:718–722
  64. Shiffman S, Engberg JB, Paty JA, Perz WG, Gnys M, Kassel JD, et al. A day at a time: Predicting smoking lapse from daily urge. Journal of Abnormal Psychology. 1997;106:104–116
  65. Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M. First lapses to smoking: Within-subjects analysis of real-time reports. Journal of Consulting and Clinical Psychology. 1996;64:366–379
  66. Shiffman S, Shadel WG, Niaura R, Khayrallah MA, Jorenby DE, Ryan CF, et al. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berlin). 2003;166:343–350
  67. Shiffman S, Waters AJ. Negative affect and smoking lapses: A prospective analysis. Journal of Consulting and Clinical Psychology. 2004;72:192–201
  68. Shiffman S, West R, Gilbert D. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine and Tobacco Research. 2004;6:559–614
  69. Shiffman S, Wills TA. Coping and substance use. Orlando, FL: Academic Press; 1985;
  70. Siegel S. Evidence from rats that morphine tolerance is a learned response. Journal of Comparative & Physiological Psychology. 1975;89:498–506
  71. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Systematic Reviews. 2004;CD000146
  72. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Systematic Reviews. 2008;CD000146
  73. Stewart J, de Wit H, Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychological Review. 1984;91:251–268
  74. Sweeney CT, Fant RV, Fagerstrom KO, McGovern JF, Henningfield JE. Combination nicotine replacement therapy for smoking cessation: Rationale, efficacy and tolerability. CNS Drugs. 2001;15:453–467
  75. Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A. Smokers deprived of cigarettes for 72 h: Effect of nicotine patches on craving and withdrawal. Psychopharmacology (Berlin). 2002;164:177–187
  76. Thewissen R, Snijders SJ, Havermans RC, van den HM, Jansen A. Renewal of cue-elicited urge to smoke: Implications for cue exposure treatment. Behaviour Research and Therapy. 2006;44:1441–1449
  77. Tiffany ST, Cox LS, Elash CA. Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. Journal of Consulting and Clinical Psychology. 2000;68:233–240
  78. Tong C, Bovbjerg DH, Erblich J. Smoking-related videos for use in cue-induced craving paradigms. Addictive Behaviors. 2007;32:3034–3044
  79. Warren CA, McDonough BE. Event-related brain potentials as indicators of smoking cue-reactivity. Clinical Neurophysiology. 1999;110:1570–1584
  80. Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH. Cue-provoked craving and nicotine replacement therapy in smoking cessation. Journal of Consulting and Clinical Psychology. 2004;72:1136–1143
  81. Wertz JM, Sayette MA. Effects of smoking opportunity on attentional bias in smokers. Psychology of Addictive Behaviors. 2001;15:268–271
  82. West R, Baker CL, Cappelleri JC, Bushmakin AG. Effect of varenicline and bupropion on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. In: Presented at the Annual meeting of the Society for Research on Nicotine & Tobacco, Austin, TX USA. 2007;
  83. West R, Schneider N. Craving for cigarettes. British Journal of Addiction. 1987;82:407–415
  84. Wikler A. Recent progress in research on the neurophysiological basis of morphine addiction. American Journal of Psychiatry. 1948;105:328–338
  85. Wikler A. Conditioning of successive adaptive responses to the initial effects of drugs. Conditional Reflex. 1973;8:193–210
  86. Wilson SJ, Sayette MA, Delgado MR, Fiez JA. Instructed smoking expectancy modulates cue-elicited neural activity: A preliminary study. Nicotine & Tobacco Research. 2005;7:637–645
  87. Wilson SJ, Sayette MA, Fiez JA. Prefrontal responses to drug cues: A neurocognitive analysis. Nature Neuroscience. 2004;7:211–214
  88. Zhang X, Chen X, Yu Y, Sun D, Ma N, He S, et al. Masked smoking-related images modulate brain activity in smokers. Human Brain Mapping. 2008;

PII: S0740-5472(08)00099-8

doi: 10.1016/j.jsat.2008.06.005

Journal of Substance Abuse Treatment
Volume 36, Issue 3 , Pages 235-243 , April 2009

Article Tools